
Sign up to save your podcasts
Or


Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.”
Together, they explore the study’s key findings, its implications for women’s health, and the growing importance of vaginal microbiota transplantation as a research frontier. They also reflect on what lies ahead for this emerging field.
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00222-8/fulltext
By The Lancet GroupElisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.”
Together, they explore the study’s key findings, its implications for women’s health, and the growing importance of vaginal microbiota transplantation as a research frontier. They also reflect on what lies ahead for this emerging field.
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00222-8/fulltext

22 Listeners

0 Listeners

0 Listeners

3 Listeners

1 Listeners

0 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

1 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners